Back

Associations between glucolipid metabolic indices with the risk and progression of cardiovascular-kidney-metabolic syndrome in MASLD: evidence from the UK biobank

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Adipose tissue, metabolic syndrome, and cardiometabolic disease Lipid Metabolism, Metabolic Syndrome, Diabetes ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Ruizhi Wang

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

5 More presentations in this session

Presentation thumbnail
Inflammatory epicardial adipose tissue–myocardial crosstalk in coronary artery disease: a single-cell analysis
Doctor S. Doppler (Munich, DE)
Abstract
Presentation thumbnail
Triple GLP-1R/GIP-R/GCGR activation synergistically suppresses macrophage-driven oxidative stress and activation in human epicardial adipose tissue from patients with a history of atrial fibrillation
Doctor W. Fakih (Strasbourg, FR)
Abstract
Presentation thumbnail
Transcriptomic profiling of dysfunctional adipose tissue defines biomarker signatures that improve diabetes risk assessment
Doctor O. Brown (Leeds, GB)
Abstract
Presentation thumbnail
Cilostazol restores endothelial function and reduces platelet hyperactivity via PKA/ENOS/PKG and NRF2 signaling in experimental metabolic syndrome
Doctor G. Lima (Strasbourg, FR)
Abstract
Presentation thumbnail
Skeletal muscle acts as a major organ for systemic oxidized LDL clearance via a CD36-dependent mechanism enhanced by physical exercise.
Professor T. Sawamura (Matsumoto, JP)
Abstract

Access the full session

Session thumbnail
Adipose tissue, metabolic syndrome, and cardiometabolic disease

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular-kidney-metabolic syndrome and association with mortality in the UK Biobank prospective cohort study
1 September 2025
thumbnail
Congress Presentation
Comparison of the triglyceride-glucose index and triglyceride-HDL ratio as discriminators of metabolic syndrome in the elderly population
30 August 2025
thumbnail
Congress Presentation
Antibody against apolipoprotein-A1, Metabolic-Associated Fatty Liver Disease and cardiovascular risk: a translational study
26 August 2023
thumbnail
Congress Session
Real-world experience from an MDT cardiometabolic clinic
23 June 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources